In vivo molecular imaging for planning radiation therapy of gliomas: An application of 1H MRSI

Journal of Magnetic Resonance Imaging

Volumn 16, Issue 4, 2002, Pages 464-476

  Nelson, Sarah J ^a,b   Graves, Edward ^a   Pirzkall, Andrea ^a   Li, Xiaojuan ^a   Chan, Antionette Antiniw ^a   Vigneron, Daniel B ^a   McKnight, Tracy R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain tumors; Improved targeting; Magnetic resonance spectroscopy; Molecular imaging; Radiation therapy

Indexed keywords

CHOLINE; CREATINE; GADOLINIUM; N ACETYLASPARTIC ACID;

CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; GLIOMA; HUMAN; IN VIVO STUDY; MOLECULAR BIOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT PLANNING; TUMOR VOLUME;

BRAIN NEOPLASMS; DOSE FRACTIONATION; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; RADIOSURGERY; RADIOTHERAPY DOSAGE;

EID: 0036793140     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.10183     Document Type: Review

References (77)

1. Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1989;16:1405-1409.
2. Walker MD, Alexander Jr E, Hunt WE, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 1978;49:333-343.
3. Walker MD, Strike TA, Sheline GE. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 1979;5:1725-1731.
4. Sheline GE, Wara WW, Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 1980;6:1215-1228.
5. Bleehen NM, Stenning SP. A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. Br J Cancer 1991;64:769-774.
6. Laramore GE, Martz KL, Nelson SJ, et al. Radiation Therapy Oncology Group (RTOG) survival data on anaplastic astrocytomas of the brain: does a more aggressive from of treatment adversely impact survival? Int J Radiat Oncol Biol Phys 1989;17:1351-1356.
7. Fitzek MM, Thornton AF, Rabinov JD, et al. Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial. J Neurosurg 1999;91:251-260.
8. Liang BC, Thornton Jr AF, Sandler HM, et al. Malignant astrocytomas: focal tumor recurrence after focal external beam radiation therapy. J Neurosurg 1991;75:559-563.
9. Hochberg FH, Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology 1980;30:907-911.
10. Nakagawa K, Aoki Y, Fujimaki T, et al. High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1998;40:1141-1149.
11. Pirzkall A, Graves EE, McKnight TR, et al. Magnetic resonance spectroscopy guided integrated boost irradiation for high grade gliomas using IMRT. Proceedings of the XIIIth International Conference on the Use of Computing Radiation Therapy. Heidelberg, Germany, May 22-25; 2000. p 156.
12. Hochberg FH, Slotnick B. Neuropsychologic impairment in astrocytoma survivors. Neurology 1980;30:172-177.
13. Bruhn H, Frahm J, Gyngell ML, et al. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology 1989;172:541-548.
14. Arnold DL, Shoubridge EA, Villemure JG, Feindel W. Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading. NMR Biomed 1990;3:184-189.
15. Langkowski JH, Wieland J, Bomsdorf H, Leibfritz D, Westphal M, Offermann W, Maas R. Pre-operative localized in vivo proton spectroscopy in cerebral tumors at 4.0 Tesla-first results. Magn Reson Imaging 1989;7:547-555.
16. Damaerel P, Johannik K, Van Hecke P, et al. Localized 1H NMR spectroscopy in fifty new cases of newly diagnosed intracranial tumors. J Comput Asst Tomogr 1991;15:67-76.
17. Alger JR, Frank JA, Bizzi A, et al. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 flourodeoxyglucose PET. Radiology 1990;177:633-641.
18. Gill SS, Thomas DG, Van Bruggen N. Proton MR spectroscopy of intracranial tumors: in vivo and in vitro studies. J Comput Assist Tomogr 1990;14:497-504.
19. Kugel H, Heindel W, Ernestus RI, Bunke J, du Mesnil R, Friedman G. Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. Radiology 1992;183:701-709.
20. Chang L, Mc Bride D, Miller BL, et al. Localized in vivo 1H magnetic resonance spectroscopy and in vitro analyses of hetergeneous brain tumors. J Neuroimaging 1995;5:157-163.
21. McBride DQ, Miller BL, Nikas DL, et al. Analysis of brain tumors using 1H magnetic resonance spectroscopy. Surg Neurol 1995;44:137-144.
22. Usenius JP, Kauppinen RA, Vaino P, et al. Quantitative metabolite patterns of human brain tumors: detection by 1H NMR spectroscopy in vivo and in vitro. J Comput Assist Tomog 1994;18:705-713.
23. Usenius J-P, Vaino P, Hemesniemi J, Kauppinen RA. Choline-containing compounds in human astrocytomas studied by 1H NMR spectroscopy in vivo and in vitro. J Neurochem 1994;63:1538-1543.
24. Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 1991;45:37-45.
25. Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multi-center trial. J Neurosurg 1996;84:449-458.
26. Heesters MA, Kamman RL, Mooyaart EL, Go KG. Localized proton spectroscopy of inoperable brain tumours. Response to radiation therapy. J Neurooncol 1993;17:27-35.
27. Shimizu H, Kumabe T, Tominaga T, et al. Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. Am J Neuroradiol 1996;17:737-747.
28. Segebarth CM, Baleriaux DF, Luyten PR, den Hollander JA. Detection of metabolic heterogeneity of human intracranial tumors in vivo by H-1 NMR spectroscopic imaging. Magn Reson Med 1990;13:62-76.
29. Luyten PR, Marien AJ, Heindel W, et al. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Radiology 1990;176:791-799.
30. Fulham MJ, Bizzi A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992;185:675-686.
31. Preul MC, Caramanos Z, Collins DL, et al. Accurate non-invasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 1996;2:323-325.
32. Rutter A, Hugenholtz H, Saunders JK, Smith IC. Classification of brain tumors by ex vivo 1H NMR spectroscopy. J Neurochem 1995;64:1655-1661.
33. Somorjai RL, Dolenko B, Nikulin et al. Classification of 1H MR spectra of human brain neoplasms: the influence of preprocessing and computerized consensus diagnosis on classification accuracy. J Magn Reson Imaging 1996;6:437-444.
34. Tate AR, Griffiths JR, Martinez-Perez I. Towards a method for automated classification of 1HY MR spectra of brain tumors. NMR Biomed 1998;11:177-191.
35. Castillo M, Smith JK, Kwock L. Correlation of myo-inositol levels and grading of cerebral astrocytomas. Am J Neuroradiol 2000;21:1645-1649.
36. Posse S, Tedeschi G, Risinger R, Ogg R, Le Bihan D. High speed 1H spectroscopic imaging in human brain by echo planar spatialspectral encoding. Magn Reson Med 1995;33:34-40.
37. Adelsteinsson E, Irarrazabal P, Spielman DM, Macovski A. Three-dimensional spectroscopic imaging with time-varying gradients. Magn Reson Med 1995;33:461-466.
38. Nelson SJ, Vigneron DB, Star-Lack J, Kurhanewicz J. High spatial resolution and speed in MRSI. NMR Biomed 1997;10:411-422.
39. Nelson SJ, Huhn S, Vigneron DB, et al. Volume MRI and MRSI techniques for the quantitation of treatment response in brain tumors: presentation of a detailed case study. J Magn Reson Imaging 1997;7:1146-1152.
40. Graves EE, Pirzkall A, Nelson SJ, Verhey L, Larson D. Registration of magnetic resonance spectroscopic imaging to computed tomography for radiotherapy treatment planning. Med Phys 2001;28:2489-2496.
41. Star-Lack J, Nelson SJ, Kurhanewicz J, Huang LR, Vigneron DB. Improved water and lipid suppression for 3-D PRESS CSI using rf band selective inversion with gradient dephasing (BASING). Magn Reson Med 1997;38:311-321
42. Star-Lack J, Vigneron DB, Pauly J, Kurhanewicz J, Nelson SJ. Improved solvent suppression and increased spatial excitation bandwidths for 3-D PRESS CSI using phase-compensating spectral/spatial spin-echo pulses. J Magn Reson Imaging 1997;7:745-757.
43. Tran T-K C, Vigneron DB, Sailasuta N, et al. Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer. Magn Reson Med 2000;43:23-33.
44. Star-Lack J, Spielman D, Adalsteinsson E, Kurhanewicz J, Terris DJ, Vigneron DB. In vivo lactate editing with simultaneous detection of choline, creatine, NAA, and lipid singlets at 1.5 T using PRESS excitation with applications to the study of brain and head and neck tumors. J Magn Reson 1998;133:243-242.
45. Spielman D, Webb P, Macovski A. A statistical framework for in vivo spectroscopic imaging. J Magn Reson 1988;79:66-77.
46. Nelson SJ, Brown TR. A study of the accuracy of quantification which can be obtained from 1-D NMR spectra using the PIQABLE algorithm. J Magn Reson 1989;84:95-109.
47. Nelson SJ. The analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors. Magn Reson Med 2001;46:228-239.
48. Spielman D, Webb P, Macovski A. Water referencing for spectroscopic imaging. Magn Reson Med 1989;12:38-49.
49. McKnight TR, Noworolski SM, Vigneron DB, Nelson SJ. An automated technique for the quantitative assessment of 3D-MRSI data from patients with glioma. J Magn Reson Imaging 2001;13:167-177.
50. Li X, Lu Y, Pirzkall A, Mcknight T, Nelson SJ. Analysis of spatial extent of the metabolic abnormality for newly diagnosed glioma patients. J Magn Reson Imaging 2002;16:229-237.
51. Pelizzari CA, Chen CT, Spelbring DR, Weichselbaum RR, Chen T. Accurate three-dimensional registration of CT, PET and/or MR images of the brain. J Comput Assist Tomogr 1989;13:20-26.
52. Pietrzyk U, Herholz K, Fink G, Jacobs A, Mielke R, Slansky I, Wurker M, Heiss WD. An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies. J Nucl Med 1994;35:2011-2018.
53. Wang C, Pahl JJ, Hogue RE. A method for co-registering three-dimensional multi-modality brain images. Comput Methods Programs Biomed 1994;44:131-140.
54. Strother SC, Anderson JR, Xu XL, Liow JS, Bonar DC, Rottenberg DA. Quantitative comparisons of image registration techniques based on high-resolution MRI of the brain. J Comput Assist Tomogr 1994;18:954-962.
55. Woods RP, Mazziotta JC, Cherry SR. MRI-PET registration with automated algorithm. J Comput Assist Tomogr 1993;17:536-546.
56. Pirzkall A, McKnight TR, Graves EE, et al. MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys 2001;50:915-928.
57. Pirzkall A, Nelson SJ, McKnight TR, et al. Metabolic imaging by means of 3D MR-spectroscopy for low-grade gliomas. Int J Radiat Oncol Biol Phys 2002;53:1254-1264.
58. Clarke LP, Velthuizen RP, Clark M. MRI measurement of brain tumor response: comparison of visual metric and automatic segmentation. Magn Reson Med 1998;16:271-279.
59. Velthuizen RP, Heine JJ, Cantor AB, Lin HB, Fletcher LM, Clarke LP. Review and evaluation of MRI non-uniformity corrections for brain tumor response measurements. Med Phys 1998;25:1655-1666.
60. Corn BW, Yousem DM, Scott CB. White matter changes are correlated significantly with radiation dose-observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02). Cancer 1994;74:2828-2835.
61. Steen RG, Koury M, Granja CI, et al. Effect of ionizing radiation on the human brain: white matter and gray matter T1 in pediatric brain tumor patients treated with conformal radiation therapy. Int J Radiat Oncol Biol Phys 2001;49:79-91.
62. Sijens PE, Vecht CJ, Levendag PC, Vandijk P, Oudkerk M. Hydrogen magnetic resonance spectroscopy follow-up after radiation therapy of human brain cancer-unexpected inverse correlation between the changes in tumor choline level and post-gadolinium magnetic resonance imaging contrast. Invest Radiol 1995;20:738-744.
63. Kumar AJ, Leeds NE, Fuller GN. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 2000;217:377-384.
64. Heesters MA, Kamman RL, Mooyaart EL, Go KG. Localized proton spectroscopy of inoperable brain gliomas-response to radiation therapy. J Neurooncol 1993,17:27-35.
65. Taylor JS Langston JW, Reddick WE. Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. Int J Radiat Oncol Biol Phys 1996;36:1251-1261.
66. Lazareff JA, Gupta RK, Alger J. Variation of post-treatment H-MRSI choline signal intensity in pediatric gliomas. J Neurooncol 1999;41:291-298.
67. Wald AA, Day MR, Nelson SJ, et al. Response of glioblastoma multiforme to brachytherapy detected by 3d proton magnetic resonance spectroscopic imaging. J Neurosurg 1997;87:525-534.
68. Virta A, Patronas N, Raman R. Spectroscopic imaging of radiation-induced effects in the white matter of glioma patients. Magn Reson Imaging 2000;18:851-857.
69. Esteve F, Rubin C, Grand S, Kolodie H, LeBas JF. Transient metabolic changes observed with proton MR spectroscopy in normal human brain after radiation therapy. Int J Radiat Oncol Biol Phys 1998;40:279-286.
70. Nelson SJ, Vigneron DB, Dillon WB. Assessment of brain tumors using volume MRI and MRSI. NMR Biomed 1999;12:123-138.
71. Graves EE, Nelson SJ, Vigneron DB, et al. A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas. J Neurosurg 2000;46:319-326.
72. Graves EE, Nelson SJ, Vigneron DB. Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery. Am J Neurorad 2001;2:613-624.
73. Wald LL, Carvajal L, Moyher SE. Phased array detectors and an automated intensity-correction algorithm for high-resolution MR imaging of the human brain. Magn Reson Med 1995;34:433-439.
74. Wald LL, Moyher SE, Day M, Nelson SJ, Vigneron DB. Proton spectroscopic imaging of the human brain using phased array detectors. Magn Reson Med 1995;34:440-445.
75. Noworolski SM, Nelson SJ, Henry RG, et al. High spatial resolution H-1 MRSI and segmented MRI of cortical gray matter and subcortical white matter in three regions of the human brain. Magn Reson Med 1999;41:21-29.
76. Vigneron D, Bollen A, McDermott M. Three-dimensional magnetic resonance spectroscopic imaging of histologically-confirmed brain tumors. Magn Reson Imaging 2001;19:89-101.
77. Cheng LL, Chang IW, Louis DN, Gonzalez RG. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. Cancer Res 1998;58:1825-1832.